Bionor Pharma   Report issue

For profit Phase 2
Founded: Oslo Norway (1993)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2008
NCT00659789
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bionor Immuno AS | Bionor Pharma AS

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 9